Exact Sciences Corp
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Diagnostics & Research
業務概覽 Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
公司地址 5505 Endeavor Lane, Madison, WI, USA, 53719
電話號碼 +1 608 284-5700
傳真號碼 +1 608 284-5701
公司網頁 https://www.exactsciences.com
員工數量 7200
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Aaron Bloomer Executive Vice President, Chief Financial Officer and Principal Accounting Officer 美元 431.87K 13/02/2026
Mr. James Herriott Senior Vice President, General Counsel and Secretary -- 13/02/2026
Mr. Kevin T. Conroy Chairman of the Board, President and Chief Executive Officer 美元 1.08M 13/02/2026
Mr. Jacob Orville Executive Vice President and General Manager, Screening 美元 618.00K 13/02/2026
Ms. Sarah Condella Executive Vice President, Human Resources 美元 509.00K 13/02/2026
Mr. Brian Baranick Executive Vice President and General Manager, Precision Oncology 美元 600.40K 13/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Michael J. Barber Independent Director 13/02/2026
Mr. D. Scott Coward Director 13/02/2026
Mr. James E. Doyle Lead Independent Director 13/02/2026
Ms. Katherine S. Zanotti Independent Director 13/02/2026
Ms. Leslie L. Trigg Independent Director 13/02/2026
Ms. Kimberly J. Popovits Independent Director 13/02/2026
Ms. Shacey Petrovic Independent Director 13/02/2026
Mr. Kevin T. Conroy Chairman of the Board, President and Chief Executive Officer 13/02/2026
Mr. Paul J. Clancy, M.B.A. Independent Director 13/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:52)
代號 名稱 佔比% ▼ 持有日期
MMIDMFS Active Mid Cap ETF<0.000001%28/11/2025
NDOWAnydrus Advantage ETF<0.000001%21/11/2025
NULGNuveen ESG Large-Cap Growth ETF<0.000001%03/06/2025
NUMGNuveen ESG Mid-Cap Growth ETF<0.000001%02/06/2025
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF<0.000001%02/06/2025
OASCOneAscent Enhanced Small and Mid Cap ETF<0.000001%08/01/2026
PBEInvesco Biotechnology & Genome ETF<0.000001%03/12/2025
PRFZInvesco RAFI US 1500 Small-Mid ETF<0.000001%23/12/2025
QUSStt Strt® SPDR® MSCI USA StratFacs ETF<0.000001%02/06/2025
QWLDState Street® SPDR® MSCI Wld StrtFcs ETF<0.000001%02/06/2025
SFYSoFi Select 500 ETF<0.000001%27/02/2026
SIZEiShares MSCI USA Size Factor ETF<0.000001%28/02/2026
SMAPAmplify Small-Mid Cap Equity ETF<0.000001%03/02/2026
SMIZZacks Small/Mid Cap ETF<0.000001%16/01/2026
THQabrdn Healthcare Opportunities<0.000001%31/01/2026
THWabrdn World Healthcare<0.000001%31/01/2026
TMEDT. Rowe Price Health Care ETF<0.000001%09/12/2025
TMFXMotley Fool Next ETF<0.000001%27/02/2026
TMSLT. Rowe Price Small-Mid Cap ETF<0.000001%14/08/2025
URTHiShares MSCI World ETF<0.000001%27/02/2026
  1    2    3    4    5    6    7   8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.